CML
Feature
Widespread carboplatin, cisplatin shortages: NCCN survey
Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.
Conference Coverage
ASCO honors Hagop Kantarjian, MD, for leukemia research
Noted Lebanese-American oncologist who leads the leukemia department at MD Anderson Cancer Center is to receive a top award at ASCO 2023.
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
Conference Coverage
CML: Preventing chemo-induced vascular toxicity
Cardiologists advise on how to ward off side effects linked to 2 TKI treatments for chronic myeloid leukemia.
Feature
Off their pricey CML meds, many thrive
For CML patients in remission, specialists suggest trying drug omission – which often yields good outcomes and a reprieve from side effects.
Conference Coverage
Momelotinib hits the mark for deadly bone marrow cancer
Phase-3 study shows superiority to danazol and highlights potential for improving outcomes in anemic myelofibrosis.
Feature
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
From the Journals
9/11 first responders show mutations linked to blood cancers
Blood samples from firefighters and emergency workers at Ground Zero show higher burden of clonal hematopoiesis, suggesting need for mutational...
From the Journals
U.S. cancer deaths continue to fall, especially lung cancer
There has been an overall decline of 32% in cancer deaths as of 2019.